Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

N-(2-aminoethyl)iminobis[N-(2-(oleoyl-cysteinyl-histidinyl-amino)ethyl)propionamide]/c(RGDfK)-polyethylene glycol-maleimide/anti-MIF short-interfering RNA nanoparticles in 10% FBS/RPMI-1640 medium

Based on

1 Articles
2012 Most recent source

Composition

1

N-(2-aminoethyl)iminobis[N-(2-(oleoyl-cysteinyl-histidinyl-amino)ethyl)propionamide]/c(RGDfK)-polyethylene glycol-maleimide/anti-MIF short-interfering RNA nanoparticles

EHCO/RGD-PEG-Mal/anti-MIF siRNA nanoparticles RGD-PEG-Mal modified EHCO/siRNA nanoparticles
Type Nano Material
Formula
Role core
2

fetal bovine serum proteins

FBS proteins
Type Biomolecule
Formula
Role layer

Properties

Applications

Area Application Source
medicine/veterinary

0 more entry available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Source
mouse mammary tumor 4T1 cells

0 more entry available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
  1. cxM00KCZHG6MMPYQ
  2. tEB26sg
Product

N-(2-aminoethyl)iminobis[N-(2-(oleoyl-cysteinyl-histidinyl-amino)ethyl)propionamide]/c(RGDfK)-polyethylene glycol-maleimide/anti-MIF short-interfering RNA nanoparticles in 10% FBS/RPMI-1640 medium

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial